Advertisement

NLS Pharma Business

Pharma Business - February 12, 2025

Lundbeck’s potential treatment for MSA receives Fast Track Designation

The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).

Financing - February 7, 2025

Herantis Pharma raises EUR 5.2 million

The company has carried out an offering of new shares in a directed share issue to institutional and other qualified investors and raises gross proceeds of EUR 5.2 million.

Pharma Business - February 3, 2025

AstraZeneca’s Imfinzi recommended for approval in the EU

AstraZeneca’s Imfinzi (durvalumab) has been recommended for approval in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following platinum-based chemoradiation therapy (CRT).

Pharma Business - January 29, 2025

AstraZeneca’s Enhertu approved in the US

Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies.

Pharma Business - January 29, 2025

Vicore Pharma granted Fast Track designation from the FDA

The United States Food and Drug Administration (FDA) has granted Fast Track designation to the company's lead candidate buloxibutid.

Global report - January 24, 2025

AstraZeneca plans USD 570 million investment in Canada

The investment in Canada will create more than 700 high-skilled jobs, across all areas of the business.

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.